Searched for
SIDDHARTH KOTAK APPOINTMENT
ET Exclusive | Biologics merger with Biocon most value-accretive option: Kiran Mazumdar ShawBiocon is fully integrating Biocon Biologics, valuing its biosimilar business at $5.5 billion. This move removes debt concerns and improves...- NSE clarifies on fake news regarding appointment of Siddharth Kotak as AI promotion chairmanThe National Stock Exchange of India (NSE) denied reports about appointing Siddharth Kotak as AI Promotion Chairman, calling them false and...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- PharmEasy’s $300M booster shotIn today’s ETtech Morning Dispatch: Ant Group may face India curbs after IPOs of Zomato and Paytm, Twitter’s troubles in India continue, Co...
- New CEO’s kitchen sinking spooks YES Bank; has stock found a bottom?Ravneet Gill's ‘kitchen sinking’ caused shares to tank 30%, wiping out nearly Rs 16,500 cr of investor money.
- Midcap IT is better off than largecap peers: Siddharth Sedani, Anand Rathi"Earnings are the mainstay of the market and that will only give the direction of the market."
- DoT all set to bring RCOM book under CAG scannerDoT is set to ask the CAG to appoint a special auditor to examine the books of Reliance Communications.
Load More